Vemurafenib for BRAF(V600E)-positive metastatic papillary thyroid cancer - Authors' response.

Vemurafenib for BRAF(V600E)-positive metastatic papillary thyroid cancer - Authors' response.

Lancet Oncol. 2016 Nov;17(11):e469

Authors: Brose MS, Singh N

PMID: 27819236 [PubMed - in process]

http://ift.tt/2ehMjN5